When imaging reaches the single-cell scale: 2–3 μm resolution is opening up new questions in the life sciences

With every step forward in the resolution of mass spectrometry imaging, researchers are able to ask a whole new set of questions. As spatial resolution advances from the tissue level to 2–3 μm, imaging begins to enter the single-cell and subcellular scales—this is not merely a matter of ‘seeing more clearly’, but of being able to answer biological questions that were previously impossible to tackle.

Trend 1: From ‘What is in the tissue?’ to ‘What is in which cell?’

Previously, at the 20–200 μm resolution, a single pixel would often cover tens or even hundreds of cells, providing only a regional average. At 2–3 μm, where a single pixel is close to the scale of a single cell, researchers can now ask: does the distribution of the same molecule differ between normal and diseased cells? How do the metabolic fingerprints of different cell types within the microenvironment differ?

New Source’s MSI LDPI is a prime example of this category; its official website states that it ‘has achieved a breakthrough spatial resolution of 3 micrometres, placing it at the forefront of the industry’. In imaging melanoma skin tissue, it visualises the distribution of metabolites across the stratum corneum, granular layer, tumour and normal tissue, revealing metabolic heterogeneity within the tumour microenvironment and demonstrating trends in abnormal tumour cell proliferation and invasion—issues that would be ‘averaged out’ at lower resolutions.

Trend 2: From ‘a single image’ to ‘subregional structure’

Even finer resolution can reconstruct the tissue structure itself. In imaging of mouse hippocampal tissue, MSI LDPI can resolve the subregions of the hippocampus, clearly presenting the spatial distribution of various metabolic molecules; following optimisation, metabolites can even achieve a spatial resolution of 4 μm. Molecular maps of subregional structures hold direct value for neuroscience and hippocampus-related physiological research.

Trend 2: From ‘Describing Distribution’ to ‘Explaining Mechanisms’

When molecular localisation aligns with cellular and subregional structures, imaging progresses from ‘describing distribution’ to ‘elucidating mechanisms’. The accumulation of cholesterol in specific brain regions, the role of lipids in pathological tissues, and the fate of drugs at the subcellular scale—these mechanistic inquiries all rely on spatial resolution capabilities at the single-cell or subcellular scale. Life sciences, medical diagnostics and drug development have therefore become key areas of focus for LDPI.

The 2–3 μm resolution does not merely yield more visually appealing images; rather, it opens up a series of more nuanced questions: which elements differ within the microenvironment, how are molecules arranged within compartmentalised structures, and which link in the mechanistic chain has undergone a change. With each step forward in resolution, the ‘whys’ that life sciences can explore gain an additional layer of depth.